News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA)


Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA) (via PR Newswire)

MILAN, May 29, 2014 /PRNewswire/ -- Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the…